BioRestorative Therapies, Inc.
BRTX
$1.57
-$0.04-2.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 50.25% | -226.37% | -49.91% | 72.91% | -81.20% |
| Total Depreciation and Amortization | 1.74% | 2.78% | 4.35% | 1.26% | 11.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -107.07% | 398.62% | 3.24% | -145.73% | 468.01% |
| Change in Net Operating Assets | 386.22% | -135.21% | -60.23% | 15.44% | 140.57% |
| Cash from Operations | 3.06% | -18.36% | -38.14% | 8.88% | 19.53% |
| Capital Expenditure | 100.00% | -193.55% | 78.80% | -65.72% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.28% | 55.56% | 55.25% | -66.92% | 161.05% |
| Cash from Investing | -9.92% | 54.44% | 63.60% | -68.49% | 160.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -16.67% | -- | -- | -- | -- |
| Issuance of Common Stock | -14.45% | -- | -100.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 133.57% | 78.79% | -4,551.56% | -34.74% |
| Cash from Financing | -18.72% | 965.16% | -- | 100.00% | -100.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -52.05% | 172.31% | -23.44% | -169.65% | 301.61% |